T 2353/19 (Single dose administration/BOEHRINGER INGELHEIM) of 03.02.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T235319.20220203
- Date of decision
- 3 February 2022
- Case number
- T 2353/19
- Petition for review of
- -
- Application number
- 12155378.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PCV2 immunogenic compositions and methods of producing such compositions
- Applicant name
- Boehringer Ingelheim Animal Health USA Inc.
- Opponent name
- Intervet International BV (opposition withdrawn)
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Agreement to text withdrawn by patent proprietor - appeal dismissed
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.